Sign in Subscribe
Pharmaceutical industry

Global Generic Drugs Market to Reach $507.8 Billion by 2026

Strategic Insights

— 2 min read

The global market for Generic Drugs is projected to reach a revised size of $507.8 Billion by 2026, growing at a compound annual growth rate (CAGR) of 5.6% over the analysis period. The COVID-19 pandemic has accelerated the growth of the generic drugs market, driven by the need for affordable and effective treatments for various chronic diseases. The market is expected to be driven by the steadily rising risk of various chronic diseases, including hypertension, obesity, and diabetes, which are fueling the demand for cost-effective generic variants.

Key Takeaways:

  • The global Generic Drugs market is estimated at $507.8 Billion by 2026, growing at a CAGR of 5.6% over the analysis period.
  • Small-Molecule Generics is projected to grow at a 5.2% CAGR to reach $325.7 Billion by the end of the analysis period.
  • The Biosimilars segment is readjusted to a revised 6.3% CAGR for the next 7-year period, currently accounting for a 37.7% share of the global Generic Drugs market.
  • The U.S. Market is estimated at $116.2 Billion in 2021, while China is forecast to reach $91.2 Billion by 2026.
  • The market is expected to be driven by the dearth of new blockbuster drugs coming into the marketplace, leading to the development of branded drugs, but generic drugs are expected to meet the majority of therapeutic needs.
  • Efforts have intensified to develop cost-effective generic variants, and several branded drugs are unable to extend their exclusivity, leading to loss of patents and giving way to the manufacture of affordable generics.
  • Major application areas for generic drugs include cardiology, anti-infection, anti-arthritis, CNS, anti-cancer, and respiratory, among others.
  • Generic drugs for CVDs represent the dominant segment currently, accounting for a majority share in the overall market.
  • Cardiovascular diseases, such as heart failure, high BP, circulatory disorders, dyslipidemia, cholesterol, arrhythmias, stroke, and angina, are the major causes of global deaths.
  • The COVID-19 pandemic emerged as a significant growth driver for the generic drugs market over the past year.
  • The demand for cheaper substitutes of branded drugs increased as economies of nations crashed because of increasing unemployment.

Statistics:

  • Global Generic Drugs Market: Estimated at $507.8 Billion by 2026.
  • Small-Molecule Generics: Projected to grow at a 5.2% CAGR to reach $325.7 Billion by the end of the analysis period.
  • Biosimilars: Readjusted to a revised 6.3% CAGR for the next 7-year period, currently accounting for a 37.7% share of the global Generic Drugs market.
  • U.S. Market: Estimated at $116.2 Billion in 2021.
  • China: Forecast to reach $91.2 Billion by 2026.
  • Global Generic Drugs Market: Expected to be driven by the steadily rising risk of various chronic diseases, including hypertension, obesity, and diabetes.
  • COVID-19 pandemic: Emerged as a significant growth driver for the generic drugs market over the past year.

Sources:

  • "Generic Drugs - Global Market Trajectory & Analytics"
  • Global Industry Analysts, Inc.
  • StrategyR.com
  • MarketGlass Platform
  • LinkedIn: @global-industry-analysts-inc.
  • Twitter: @marketbytes

Read more